生物活性 | |||
---|---|---|---|
描述 | EAI001 is a potent and selective allosteric inhibitor of the mutant epidermal growth factor receptor (EGFR), exhibiting an IC50 of 24 nM for the EGFRL858R/T790M mutation. It is utilized in the research of cancer[1][2]. EAI001, at a concentration of 50 μM, interacts with the EGFR T790M/C797S/V948R mutation, which is situated deep within the EGFR near the ATP binding site and the C-helix. The inhibitory effect of EAI001 is attributed to hydrophobic interactions with the amino acids Ile759, Leu747, Leu788, Leu777, and Met766[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.86mL 0.57mL 0.29mL |
14.31mL 2.86mL 1.43mL |
28.62mL 5.72mL 2.86mL |
参考文献 |
---|